210 related articles for article (PubMed ID: 4347503)
21. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
22. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
[TBL] [Abstract][Full Text] [Related]
23. Immunology of genitourinary tumors.
Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
[No Abstract] [Full Text] [Related]
24. [Statistical notes on urinary tract neoplasms studied in the last 20 years in the urologic department of the hospital in Vercelli].
De Benedetti H; Conti PG; Barasolo E
Minerva Urol; 1974; 26(1):21-4. PubMed ID: 4424749
[No Abstract] [Full Text] [Related]
25. [Check-ups for malignant urologic tumors].
Lent V
Dtsch Med Wochenschr; 1975 Nov; 100(47):2452-4. PubMed ID: 1237393
[No Abstract] [Full Text] [Related]
26. Cancer genetics: urological system. II.
Lynch HT
Nebr Med J; 1974 Dec; 59(12):460-5. PubMed ID: 4372563
[No Abstract] [Full Text] [Related]
27. The diagnosis of genitourinary neoplasms.
Redman JF; Bissada NK
J Ark Med Soc; 1975 May; 71(12):393-6. PubMed ID: 123911
[No Abstract] [Full Text] [Related]
28. Evaluation of serum prostate-specific antigen in urologic cancers.
Takeuchi T; Kuriyama M; Fujihiro S; Fujimoto Y; Okano M; Nishiura T
J Surg Oncol; 1983 Oct; 24(2):157-60. PubMed ID: 6195484
[TBL] [Abstract][Full Text] [Related]
29. Carcinoembryonic antigen in patients with urologic cancers.
Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
[No Abstract] [Full Text] [Related]
30. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
31. [Urogenital cancer in children].
Santander E; Lopez V
Rev Venez Urol; 1970; 22(3):181-208. PubMed ID: 4328522
[No Abstract] [Full Text] [Related]
32. [Radiotherapy of urologic cancer].
Mikuriya S
Gan No Rinsho; 1987 Mar; Spec No():405-15. PubMed ID: 3599440
[No Abstract] [Full Text] [Related]
33. [The presence of HLA-A2 antigens on lymphocytes - protection against tumors?].
Májský A; Abrahámová J
Cas Lek Cesk; 1980 Jan; 119(2):47-50. PubMed ID: 6245809
[No Abstract] [Full Text] [Related]
34. [Biopsy in urologic tumor diagnosis].
Pupato F
Ther Umsch; 1970 May; 27(5):314-26. PubMed ID: 5534338
[No Abstract] [Full Text] [Related]
35. The value of urinary neopterin as an immunological parameter in patients with malignant tumors of the genitourinary tract.
Frick J; Aulitzky W; Fuchs D; Hausen A; Joos H; Reibnegger G; Wachter H
Urol Int; 1985; 40(3):155-9. PubMed ID: 3874460
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic errors in urologic tumors].
Horn G; Baumann W
Z Urol Nephrol; 1971 Apr; 64(4):256-70. PubMed ID: 5106570
[No Abstract] [Full Text] [Related]
37. Prostate and transitional cell carcinoma: radioimmunoassay of viral tumor-associated antigens.
Mickey DD; Paulson DF
Natl Cancer Inst Monogr; 1978 Dec; (49):51-3. PubMed ID: 86167
[TBL] [Abstract][Full Text] [Related]
38. Referral pattern of urological malignancy in Indonesia.
Sugandi S
Br J Urol; 1989 Jan; 63(1):1-3. PubMed ID: 2537672
[TBL] [Abstract][Full Text] [Related]
39. Tissue antibodies in malignant and benign urogenital disease.
Kurki R; Linder E; Miettinen A; Alfthan O; Heikkinen A; Pasternack A
Int J Cancer; 1977 Mar; 19(3):332-6. PubMed ID: 321365
[TBL] [Abstract][Full Text] [Related]
40. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.
Catalona WJ; Ratliff TL; McCool RE
J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
